74 related articles for article (PubMed ID: 26373825)
1. Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer.
Pritchard T; Rosengren RJ; Greish K; Taurin S
J Drug Target; 2016; 24(5):441-9. PubMed ID: 26373825
[TBL] [Abstract][Full Text] [Related]
2. A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.
Taurin S; Nehoff H; van Aswegen T; Rosengren RJ; Greish K
Biomed Res Int; 2014; 2014():323594. PubMed ID: 24689036
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor.
Greish K; Nehoff H; Bahman F; Pritchard T; Taurin S
J Drug Target; 2019 Sep; 27(8):903-916. PubMed ID: 30615483
[TBL] [Abstract][Full Text] [Related]
6. A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.
Archibald M; Pritchard T; Nehoff H; Rosengren RJ; Greish K; Taurin S
Int J Nanomedicine; 2016; 11():179-200. PubMed ID: 26811677
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
[TBL] [Abstract][Full Text] [Related]
8. Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer.
Martey O; Nimick M; Taurin S; Sundararajan V; Greish K; Rosengren RJ
Int J Nanomedicine; 2017; 12():7225-7237. PubMed ID: 29042771
[TBL] [Abstract][Full Text] [Related]
9. Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease.
Greish K; Taha S; Jasim A; Elghany SA; Sultan A; AlKhateeb A; Othman M; Jun F; Taurin S; Bakhiet M
Clin Transl Med; 2017 Dec; 6(1):28. PubMed ID: 28770521
[TBL] [Abstract][Full Text] [Related]
10. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
Greish K; Nagamitsu A; Fang J; Maeda H
Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
[TBL] [Abstract][Full Text] [Related]
11. Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo.
Zhao J; Liu J; Wei T; Ma X; Cheng Q; Huo S; Zhang C; Zhang Y; Duan X; Liang XJ
Nanoscale; 2016 Mar; 8(9):5126-38. PubMed ID: 26875690
[TBL] [Abstract][Full Text] [Related]
12. The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer.
Xian S; Parayath NN; Nehoff H; Giles NM; Greish K
Anticancer Res; 2015 Sep; 35(9):4707-12. PubMed ID: 26254360
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
Daruwalla J; Nikfarjam M; Greish K; Malcontenti-Wilson C; Muralidharan V; Christophi C; Maeda H
Cancer Sci; 2010 Aug; 101(8):1866-74. PubMed ID: 20579075
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
[TBL] [Abstract][Full Text] [Related]
15. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
Greish K; Sawa T; Fang J; Akaike T; Maeda H
J Control Release; 2004 Jun; 97(2):219-30. PubMed ID: 15196749
[TBL] [Abstract][Full Text] [Related]
16. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer.
Palmer H; Nimick M; Mazumder A; Taurin S; Rana Z; Rosengren RJ
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453603
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
19. HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect.
Fang J; Greish K; Qin H; Liao L; Nakamura H; Takeya M; Maeda H
Eur J Pharm Biopharm; 2012 Aug; 81(3):540-7. PubMed ID: 22576132
[TBL] [Abstract][Full Text] [Related]
20. Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells.
Parayath NN; Nehoff H; Müller P; Taurin S; Greish K
Int J Nanomedicine; 2015; 10():4653-67. PubMed ID: 26229468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
